Clinical benefit of evolocumab by severity and extent of coronary artery disease: an analysis from FOURIER

被引：0
|
作者：
Leitner, H.
机构：
来源：
JOURNAL FUR KARDIOLOGIE | 2018年 / 25卷 / 9-10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [1] Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
    Sabatine, Marc S.
    De Ferrari, Gaetano M.
    Giugliano, Robert P.
    Huber, Kurt
    Lewis, Basil S.
    Ferreira, Jorge
    Kuder, Julia F.
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Kurtz, Christopher E.
    Honarpour, Narimon
    Keech, Anthony C.
    Sever, Peter S.
    Pedersen, Terje R.
    CIRCULATION, 2018, 138 (08) : 756 - 766
  • [2] Clinical Benefit of Evolocumab in Patients With a History of MI: An Analysis From FOURIER
    Sabatine, Marc S.
    de Ferrari, Gaetano M.
    Giugliano, Robert P.
    Huber, Kurt
    Lewis, Basil S.
    Ferreira, Jorge
    Kuder, Julia F.
    Murphy, Sabina A.
    Wiviott, Steven D.
    Kurtz, Christopher
    Honarpour, Narimon
    Keech, Anthony C.
    Sever, Peter S.
    Pedersen, Terje R.
    CIRCULATION, 2017, 136 (24) : E452 - E453
  • [3] Relationship of activin A levels with clinical presentation, extent, and severity of coronary artery disease
    Bouzidi, Nadia
    Betbout, Fethi
    Maatouk, Faouzi
    Gamra, Habib
    Miled, Abdelhedi
    Ferchichi, Salima
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 18 (06): : 402 - 409
  • [4] Gender differences in the severity and extent of coronary artery disease
    Chiha, Joseph
    Mitchell, Paul
    Gopinath, Bamini
    Plant, Adam J. H.
    Kovoor, Pramesh
    Thiagalingama, Aravinda
    IJC HEART & VASCULATURE, 2015, 8 : 161 - 166
  • [5] Hyperhomocysteinaemia is independently predictive of severity and extent of coronary artery disease
    Qiao, M
    Chook, P
    Chan, A
    Poon, PYK
    Chan, WWM
    Tse, LKK
    Sanderson, JE
    Woo, KS
    EUROPEAN HEART JOURNAL, 2002, 23 : 414 - 414
  • [6] The effects of hyperhomocysteinemia on the presence, extent, and severity of coronary artery disease
    Bozkurt, A
    Toyaksi, H
    Acartürk, E
    Tuli, A
    Çayli, M
    JAPANESE HEART JOURNAL, 2003, 44 (03): : 357 - 368
  • [7] Association of metabolic syndrome with coronary artery disease extent and severity
    Veseli, A. Aferdita
    Alimehmeti, I.
    Gjergo, H.
    Seiti, J.
    Demiri, E.
    Kabili, S.
    Horjeti, B.
    Lezha, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 468 - 468
  • [8] RELATIONSHIP BETWEEN SPHINGOMYELINASE, CERAMIDE AND CLINICAL PRESENTATION, EXTENT AND SEVERITY OF ATHEROSCLEROTIC CORONARY ARTERY DISEASE
    Yu, Jingjia
    Pan, Wei
    Yang, Tianlun
    Zhang, Guogang
    Shi, Ruizheng
    HEART, 2012, 98 : E177 - E177
  • [9] RELATION BETWEEN EXTENT OF CORONARY-ARTERY DISEASE AND SEVERITY OF HYPERLIPOPROTEINEMIA
    MURRAY, RG
    TWEDDEL, A
    THIRD, JLHC
    HUTTON, I
    HILLIS, WS
    LORIMER, AR
    LAWRIE, TDV
    BRITISH HEART JOURNAL, 1975, 37 (12): : 1205 - 1209
  • [10] Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease
    Neunteufl, T
    Katzenschlager, R
    Hassan, A
    Klaar, U
    Schwarzacher, S
    Glogar, D
    Bauer, P
    Weidinger, F
    ATHEROSCLEROSIS, 1997, 129 (01) : 111 - 118
12345